1. Summary of revisions: standards of medical care in diabetes-2018;Diabetes Care,2018
2. Heart failure: a cardiovascular outcome in diabetes that can no longer be ignored;McMurray;Lancet Diabetes Endocrinol,2014
3. 10-year follow-up of intensive glucose control in type 2 diabetes;Holman;N Engl J Med,2008
4. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes;Nissen;N Engl J Med,2007
5. U.S. Food and Drug Administration. Guidance for Industry: Diabetes Mellitus Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes. 2008. Available at: www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm071627.pdf. Accessed November 24, 2017.